Fed. Circ. Upholds AstraZeneca's Seroquel Patent Win
The U.S. Court of Appeals for the Federal Circuit has upheld a lower court's ruling that AstraZeneca Pharmaceuticals LP did not engage in inequitable conduct when seeking a patent for its...To view the full article, register now.
Already a subscriber? Click here to view full article